Cargando…

The influence of different long-circulating materials on the pharmacokinetics of liposomal vincristine sulfate

PURPOSE: This study was designed to improve the in vivo pharmacokinetics of long-circulating vincristine sulfate (VS)-loaded liposomes; three different long-circulating materials, chitosan, poly(ethylene glycol)-1,2-distearoyl sn-glycero-3-phosphatidylethanolamine (PEG-DSPE), and poly(ethylene glyco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jing, Chen, Yingchong, Li, Xiang, Liang, Xinli, Luo, Xiaojian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008646/ https://www.ncbi.nlm.nih.gov/pubmed/27616886 http://dx.doi.org/10.2147/IJN.S109547

Ejemplares similares

Marqibo(®) (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine
por: Silverman, Jeffrey A., et al.
Publicado: (2012)

Pharmacokinetic Behavior of Vincristine and Safety Following Intravenous Administration of Vincristine Sulfate Liposome Injection in Chinese Patients With Malignant Lymphoma
por: Yang, Fen, et al.
Publicado: (2018)

Vincristine sulfate liposomal injection for acute lymphoblastic leukemia
por: Raj, Trisha A Soosay, et al.
Publicado: (2013)

Vincristine sulfate liposomal injection for acute lymphoblastic leukemia [Corrigendum]
Publicado: (2013)

Clinical Pharmacokinetics and Effects of Vincristine Sulfate in Dogs with Transmissible Venereal Tumor (TVT)
por: HANTRAKUL, Supannika, et al.
Publicado: (2014)

Conventional-Vincristine Sulfate vs. Modified Protocol of Vincristine Sulfate and L-Asparaginase in Canine Transmissible Venereal Tumor
por: Setthawongsin, Chanokchon, et al.
Publicado: (2019)

Preparation and Pharmacokinetic Study of Daidzein Long-Circulating Liposomes
por: Wang, Qiao, et al.
Publicado: (2019)

Characterization and Pharmacokinetic Evaluation of Oxaliplatin Long-Circulating Liposomes
por: Cheraga, Nihad, et al.
Publicado: (2021)

Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models.
por: Webb, M. S., et al.
Publicado: (1995)

Delivery of vincristine sulfate-conjugated gold nanoparticles using liposomes: a light-responsive nanocarrier with enhanced antitumor efficiency
por: Liu, Ying, et al.
Publicado: (2015)

Development and characteristics of novel sonosensitive liposomes for vincristine bitartrate
por: Lin, Wen, et al.
Publicado: (2019)

Vincristine Sulfate Liposome Injection with Bendamustine and Rituximab as First-Line Therapy for B-Cell Lymphomas: A Phase I Study
por: Ollila, Thomas, et al.
Publicado: (2022)

Characterization of highly stable liposomal and immunoliposomal formulations of vincristine and vinblastine
por: Noble, Charles O., et al.
Publicado: (2009)

Development of a stable single-vial liposomal formulation for vincristine
por: Mao, Wenxue, et al.
Publicado: (2019)

Genetic Polymorphisms Associated with Vincristine Pharmacokinetics and Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology Patients
por: van de Velde, Mirjam E., et al.
Publicado: (2022)

Vincristine liposomes with smaller particle size have stronger diffusion ability in tumor and improve tumor accumulation of vincristine significantly
por: Ma, Siyu, et al.
Publicado: (2017)

A Pilot Phase II Study of the Feasibility and Efficacy of Vincristine Sulfate Liposome Injection in Patients With Relapsed or Refractory Acute Myeloid Leukemia
por: Seegars, Mary Beth, et al.
Publicado: (2021)

A Population Pharmacokinetic Modelling Approach to Unravel the Complex Pharmacokinetics of Vincristine in Children
por: Nijstad, A. Laura, et al.
Publicado: (2022)

Epigallocatechin‐3‐gallate sensitises multidrug‐resistant oral carcinoma xenografts to vincristine sulfate
por: Chen, Li, et al.
Publicado: (2020)

Correction to “Folic acid-conjugated liposomal vincristine for multidrug resistant cancer therapy”
por: Wang, Chenyu, et al.
Publicado: (2022)

Dual-modified liposome codelivery of doxorubicin and vincristine improve targeting and therapeutic efficacy of glioma
por: Zhang, Yue, et al.
Publicado: (2017)

Hyperlipidemia Alters the Pharmacokinetics of Posaconazole and Vincristine Upon Co-Administration in Rats
por: Khalil, Hadeel A., et al.
Publicado: (2017)

Treating relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemia: liposome-encapsulated vincristine
por: Davis, Tyler, et al.
Publicado: (2013)

Nonspecifically enhanced therapeutic effects of vincristine on multidrug-resistant cancers when coencapsulated with quinine in liposomes
por: Xu, Yuzhen, et al.
Publicado: (2015)

Pharmacogenomics of Vincristine‐Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes
por: Wright, Galen E.B., et al.
Publicado: (2018)

Application of functional vincristine plus dasatinib liposomes to deletion of vasculogenic mimicry channels in triple-negative breast cancer
por: Zeng, Fan, et al.
Publicado: (2015)

Vincristine Chemotherapy Trials and Pharmacokinetics in Tasmanian Devils with Tasmanian Devil Facial Tumor Disease
por: Phalen, David N., et al.
Publicado: (2013)

Population Pharmacokinetics of Vincristine Related to Infusion Duration and Peripheral Neuropathy in Pediatric Oncology Patients
por: van de Velde, Mirjam Esther, et al.
Publicado: (2020)

The hepatoprotective and antioxidative effect of saffron stigma alcoholic extract against vincristine sulfate induced toxicity in rats
por: HARCHEGANI, Asghar Beigi, et al.
Publicado: (2019)

Pharmacology of liposomal vincristine in mice bearing L1210 ascitic and B16/BL6 solid tumours.
por: Mayer, L. D., et al.
Publicado: (1995)

Hyaluronan Polymer Length, Grafting Density, and Surface Poly(ethylene glycol) Coating Influence in Vivo Circulation and Tumor Targeting of Hyaluronan-Grafted Liposomes
por: Qhattal, Hussaini Syed Sha, et al.
Publicado: (2014)

Pharmacokinetic Analyses of Liposomal and Non-Liposomal Multivitamin/Mineral Formulations
por: Ko, Joungbo, et al.
Publicado: (2023)

Liposomal Vincristine as a Bridge Therapy Prior to CAR-T Therapy in Relapsed and Refractory Diffuse Large B-Cell Lymphoma?
por: Chadha, Juskaran, et al.
Publicado: (2019)

Pharmacokinetics of a liposomal formulation of doxorubicin in rats
por: Liu, Zongyu, et al.
Publicado: (2017)

Long-Circulating Thermosensitive Liposomes for the Targeted Drug Delivery of Oxaliplatin
por: Li, Yanan, et al.
Publicado: (2020)

2535. Physiological-based pharmacokinetic analysis of drug–drug interactions between isavuconazole and vincristine in pediatric subjects
por: Choules, Mary P, et al.
Publicado: (2023)

Vincristine-Induced Cranial Neuropathy
por: TALEBIAN, Ahmad, et al.
Publicado: (2014)

Identification of small molecules that mitigate vincristine‐induced neurotoxicity while sensitizing leukemia cells to vincristine
por: Diouf, Barthelemy, et al.
Publicado: (2021)

Vinorelbine as substitute for vincristine in patients with diffuse large B cell lymphoma and vincristine-induced neuropathy
por: Hatzl, Stefan, et al.
Publicado: (2021)

Co-Delivery of Gemcitabine and Paclitaxel in cRGD-Modified Long Circulating Nanoparticles with Asymmetric Lipid Layers for Breast Cancer Treatment
por: Zhang, Jing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rc8b59h0tqu8cjg5ha5q5q05th